This text is a result of machine translation.
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
PingPong Among First Asian Payment Firms to Support Wero Transactions
Global payment platform PingPong recently announced it will be among the first Asian payment companies to support business use of Wero. In October this year, Wero will launch its To B payment service. After launch, businesses will be able to access this unified European digital payment service via PingPong, reaching 250 million European users.
Aug 07, 2025 04:08 PM
Microsoft, Meta, Apple and Amazon Released Earnings Reports, All Surpassing Expectations
On July 31, Microsoft and Meta respectively released their latest quarterly earnings reports, with both performances far exceeding market expectations.
Aug 01, 2025 04:54 PM
A number of enterprises on the science and innovation board are listed on the "white list" of key enterprises for operation guarantee and transfer
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
Fengtai District of Beijing will lift the epidemic prevention zone of the whole region from now on.
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%